WSI더블유에스아이
299170 · KOSDAQ · ₩299170 · 더블유에스아이
- Market cap
- ₩48B
- Enterprise value
- ₩51B
- P/E
- —
- P/B
- 0.8×
- Dividend yield
- 0.0%
- ROE
- −1.3%
- Net margin
- −1.5%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−76.9% from the high
₩1,012Today: ₩1,127 – ₩1,178₩5,000
Returns
- 1W−3.7%
- 1M−17.3%
- 3M−2.4%
- 6M−52.5%
- YTD−60.6%
- 1Y−42.4%
- Volume today
- 186,840
- 0.2× the 20-day average
- Traded today
- ₩214M
- Listed shares
- 41,511,288
- EPS (12 months)
- −₩19
- Earnings yield −1.6%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 26 of 100 (50 is a normal day for this stock).
- MomentumWeak-19.7% over the last month; the price is below its 20-day average.
- News impactLow1 news items and filings in two weeks; 0 rated high impact, 0 medium.
Signals describe activity, not recommendations. Not financial advice.
WSI stock overview
WSI (더블유에스아이, KRX: 299170) is listed on KOSDAQ, in the Retail & Trade sector. The company is a Korean healthcare firm that distributes pharmaceuticals and medical devices, mainly for spine and joint surgery, and is expanding into pharmaceutical manufacturing and surgical assistant robots. Its shares closed at ₩1,157 on Oct 30, 2026, down 1.11% on the day, giving it a market value of ₩48B.
Key facts
- Market cap
- ₩48B
- Sector
- Retail & Trade
- Latest price change
- −1.11%
- As of
- Oct 30, 2026
- Main business
- The company is a Korean healthcare firm that distributes pharmaceuticals and medical devices, mainly for spine and joint surgery, and is expanding into pharmaceutical manufacturing and surgical assistant robots.
Quick answers about WSI
- What does WSI do?
- The company is a Korean healthcare firm that distributes pharmaceuticals and medical devices, mainly for spine and joint surgery, and is expanding into pharmaceutical manufacturing and surgical assistant robots. Its main product is a topical hemostatic agent, and its customers include spine and joint medical institutions in Korea and abroad. Through subsidiaries it operates in pharmaceutical development and manufacturing, medical robot development, and clinical trial sample analysis.
- What is the market cap of WSI?
- The market capitalisation of WSI was ₩48B at the close on Oct 30, 2026.
- Who are the largest shareholders of WSI?
- According to the latest official filings, the largest reported holders are Park Jeong-seop (44.90%, as of Aug 7, 2026); A-One Asset Management (4.60%, as of Aug 4, 2025); Korea Securities Finance (4.15%, as of Apr 9, 2026).
- When is the next earnings report from WSI?
- Korean companies rarely announce results dates in advance. Based on when WSI filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
Company profile
The company is a Korean healthcare firm that distributes pharmaceuticals and medical devices, mainly for spine and joint surgery, and is expanding into pharmaceutical manufacturing and surgical assistant robots. Its main product is a topical hemostatic agent, and its customers include spine and joint medical institutions in Korea and abroad. Through subsidiaries it operates in pharmaceutical development and manufacturing, medical robot development, and clinical trial sample analysis.
Written by AI from the company's latest annual report.
- Korean name
- 더블유에스아이
- Sector
- Retail & Trade
- CEO
- 이윤석
- Founded
- May 2018
- Listed
- Sep 2018
- Listed shares
- 41,511,288
- Fiscal year ends
- Month 12
- Website
- wsi-healthcare.com/
Similar companies
- Samsung C&T028260 · ₩51T₩312,000−3.55%
- POSCO International047050 · ₩8.6T₩48,650−1.22%
- ISC095340 · ₩3.3T₩155,800−6.26%
- Youngone111770 · ₩3.1T₩69,100+0.88%
- Dong SUH Companies026960 · ₩2.8T₩28,450+2.34%
- SK Gas018670 · ₩2.4T₩256,000+1.39%
- Lotte Shopping023530 · ₩2.3T₩81,900−0.49%
- Shinsegae004170 · ₩2.3T₩245,000−1.21%
Recent filings
See all- Notice of shareholders' meetingOct 23, 2026
- Determination of Shareholder Register Closure Period or Record DateOct 1, 2026
- Shareholders' meeting calledOct 1, 2026
- Half-year report (Jun 2026)Aug 14, 2026
- 5%+ holding reportAug 7, 2026
Titles in Korean until English translations are added.
Also known as: WSI / 더블유에스아이 / 299170 / KRX:299170
Source: KRX statistical information